US62955J1034 - Common Stock
NOV stock results show that NOV beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NOV (NYSE:NOV) just reported results for the second quarter of 2024.NOV reporte...
Growth stock bargains can still be unearthed, even with the Nasdaq Composite recently climbing to a fresh all-time high.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NOV (NYSE:NOV) just reported results for the first quarter of 2024.NOV reported...
NOV stock results show that NOV beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
NOV's stock tumbles despite beating Q4 earnings estimates after guiding 2024 revenues below analyst expectations and saying it faced more supply chain disruptions than peers.
National Oilwell Varco (NOV) exceeds expectations with Q4 earnings: beats GAAP EPS by $1.09 and revenue by $80M, displaying a 13% YoY growth.
Strong GDP data gave consumer stocks a boost.
This article discusses the Q4 earnings estimates for various stocks according to Morgan Stanley's Mike Wilson.
Benchmark downgrades six oilfield services stocks to Hold from Buy, citing expected range-bound crude oil prices and lower drilling U.S. activity in 2024.
Some diabetes patients are reportedly facing hurdles getting their insurers to cover GLP-1 drugs like Novo Nordisk's Ozempic and Eli Lilly's Mounjaro. Read more here.
J.P. Morgan upgrades NOV (NOV) as it benefits from international activity, technology offerings, and pent-up demand for spare parts.